Trends in Drug Delivery

Trends in Drug Delivery

The journal welcomes contributions across the following topic areas:

• Drug Delivery Systems: oral and gastrointestinal delivery, parenteral and intravenous delivery, sublingual and buccal delivery, topical and dermal delivery, transdermal drug delivery systems, inhaled and pulmonary delivery, rectal and colonic delivery, vaginal delivery and mucosal systems, ocular and ophthalmic delivery, neural and intrathecal delivery, gene and nucleic acid delivery, siRNA and RNA interference systems, and route-specific pharmacokinetics and efficacy
• Drug Carriers & Nanocarriers: liposomes and lipid-based vesicles, polymeric micelles and polymeric nanoparticles, nanostructures and nanofibres, protein-DNA complexes and polyplexes, protein-drug conjugates and bioconjugates, erythrocyte-based carriers and ghost cells, inorganic nanoparticles and metal carriers, dendrimers and dendritic systems, microparticles and microspheres, and carrier characterization and biocompatibility
• Nanoformulation & Nanotechnology: nanoformulated pharmaceuticals and nutraceuticals, bionanotechnology applications, flavonoid nanoformulations, undernutrition and therapeutic nanonutrients, nano-drug bioavailability and absorption, nanotoxicology and safety assessment, nanomaterial characterization and quality control, and clinical translation of nanomedicines
• Surface Modification & Engineering: mechanical surface modification techniques, chemical surface modification and functionalization, sol-gel coating and oxidation, ion implantation and surface activation, carburization and material hardening, protein and antibody coating, targeting ligand attachment, stealth and PEG functionalization, and surface characterization and stability
• Image-Guided Drug Therapy & Theranostics: MR imaging and drug therapy integration, CT imaging and therapeutic guidance, fluorescence imaging and real-time monitoring, spectroscopic imaging and analysis, targeted drug delivery with imaging, theranostic nanoparticles and agents, combination imaging and therapy, cancer therapy and imaging, surgical guidance and image-directed procedures, renal clearance and imaging biodistribution, and clinical applications and outcomes
• Drug-Delivery Devices & Instrumentation: prefilled syringes and ready-to-use devices, autoinjectors and self-injection systems, infusion pumps and programmable delivery, metered dose inhalers and MDI devices, nebulizers and aerosol delivery, nasal sprays and spray devices, eyedroppers and ophthalmic dispensers, intrauterine devices and long-acting systems, transdermal patches and adhesive systems, wearable and implantable delivery devices, and device design and clinical utility
• Experimental & Clinical Therapeutics: clinical pharmacology and drug effects, experimental pharmacology and mechanisms, cardiovascular drug delivery and therapy, blood pressure management and antihypertensives, heart disease and heart failure treatment, pharmacokinetic analysis and dosing, pharmacodynamic assessment and response, toxicology and safety evaluation, disease-state modeling and treatment, and therapeutic outcomes and efficacy
• Cellular Crosstalk & Signaling: transmembrane communications and signaling, lymphocyte activation and immunology, cell-cell interactions and communication, immune cell targeting and delivery, cellular uptake and internalization, receptor-ligand interactions, endocytosis and intracellular trafficking, cellular toxicity and biocompatibility, and mechanistic studies of cellular response
• Targeted & Selective Delivery: active targeting and ligand-based delivery, passive targeting and EPR effects, antibody-based targeting, peptide-based targeting ligands, vitamin and receptor-mediated targeting, enzyme-responsive delivery systems, stimuli-responsive delivery and activation, dual and multi-modal targeting, and selectivity and specificity assessment